Articaine and Nitroglycerin Transdermal Patch: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Articaine
No brand names on recordNitroglycerin Transdermal Patch
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of methemoglobinemia
Interaction Deep Dive
Coadministration of articaine/EPINEPHrine with nitrates/nitrites may increase the risk of developing methemoglobinemia. Signs of methemoglobinemia may occur immediately or may be delayed some hours after exposure, and are characterized by a cyanotic skin discoloration and/or abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore, immediate treatment is required to avert more serious central nervous system and cardiovascular adverse effects, including seizures, coma, arrhythmias, and death. Discontinue articaine/EPINEPHrine and any other oxidizing agents. Depending on the severity of the signs and symptoms, patients may respond to supportive care. A more severe clinical presentation may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen1.
Why it happens (mechanism)
Unknown
Common questions
Can I take Articaine and Nitroglycerin Transdermal Patch together?
An increased risk of methemoglobinemia Always confirm with your pharmacist or prescriber before making any change.
How serious is the Articaine and Nitroglycerin Transdermal Patch interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Articaine or Nitroglycerin Transdermal Patch need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ORABLOC(R) intraoral submucosal injection, articaine HCl epinephrine intraoral submucosal injection. Pierrel S.p.A. (per FDA), Capua, CE, Italy, 2025.
Keep reading about Articaine
Keep reading about Nitroglycerin Transdermal Patch
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist